Allarity Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 0.8704 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 13.85M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced ...